ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,838.50
      -0.46%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gossamer Bio Inc (GOSS)

      7. Gossamer Bio Inc (GOSS) News

      GOSS

      Gossamer Bio (GOSS)

      Gossamer Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GOSS
      DateTimeSourceHeadlineSymbolCompany
      06/10/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      06/07/20244:30PMBusiness WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
      06/06/20249:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      05/14/20244:01PMBusiness WireGossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International ConferenceNASDAQ:GOSSGossamer Bio Inc
      05/10/20244:30PMBusiness WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
      05/07/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      05/07/20244:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GOSSGossamer Bio Inc
      05/07/20244:01PMBusiness WireGossamer Bio Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
      05/06/20247:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      05/06/20247:30AMBusiness WireGossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other IndicationsNASDAQ:GOSSGossamer Bio Inc
      05/03/20248:02AMBusiness WireGossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory MedicineNASDAQ:GOSSGossamer Bio Inc
      03/12/20247:31AMBusiness WireGossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of DirectorsNASDAQ:GOSSGossamer Bio Inc
      03/05/20247:37AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GOSSGossamer Bio Inc
      03/05/20247:32AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GOSSGossamer Bio Inc
      03/05/20247:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      03/05/20247:31AMBusiness WireGossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
      03/04/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      01/08/20244:01PMBusiness WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
      01/04/20245:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      01/04/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      01/04/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      12/13/20234:01PMBusiness WireGossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023NASDAQ:GOSSGossamer Bio Inc
      12/05/20235:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      12/05/20235:09PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      12/05/20234:01PMBusiness WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
      12/05/20237:01AMBusiness WireGossamer Bio Appoints Bob Smith as Chief Commercial OfficerNASDAQ:GOSSGossamer Bio Inc
      11/29/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      11/29/20237:01AMBusiness WireGossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of DirectorsNASDAQ:GOSSGossamer Bio Inc
      11/27/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      11/22/20237:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
       Showing the most relevant articles for your search:NASDAQ:GOSS